House dust mite immunotherapy in Germany: real-world adherence to a  subcutaneous allergoid and a sublingual tablet

ConclusionIn this retrospective real-world cohort analysis in Germany, patients on subcutaneous AIT for HDM respiratory allergy achieved significantly higher adherence rates compared to the HDM-SLIT tablet over a  3-year treatment period. In addition, days on therapy were significantly higher for SCIT than for SLIT. It was shown that in real life significantly more patients receiving SCIT stay on the recommended treatment period of 3 years compared to SLIT subjects. This is important since effectiveness ha s been demonstrated to be linked with therapy duration.
Source: Allergo Journal International - Category: Allergy & Immunology Source Type: research